Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1548-1552, December 1995

Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men

  • Erica J.M. Velthuis-te Wierik

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Erica J.M. Velthuis-te Wierik, MSc, TNO Nutrition and Food Research Institute, Department of Physiology and Kinetics, PO Box 360, 3700 AJ Zeist, The Netherlands.
    • Netherlands Organization for Applied Scientific Research (TNO) Nutrition and Food Research Institute, Zeist, The Netherlands
    • TNO Prevention and Health, Gaubius Institute, Leiden, The Netherlands
  • ,
  • Piet Meijer

      Affiliations

    • Netherlands Organization for Applied Scientific Research (TNO) Nutrition and Food Research Institute, Zeist, The Netherlands
    • TNO Prevention and Health, Gaubius Institute, Leiden, The Netherlands
  • ,
  • Cornelis Kluft

      Affiliations

    • Netherlands Organization for Applied Scientific Research (TNO) Nutrition and Food Research Institute, Zeist, The Netherlands
    • TNO Prevention and Health, Gaubius Institute, Leiden, The Netherlands
  • ,
  • Henk van den Berg

      Affiliations

    • Netherlands Organization for Applied Scientific Research (TNO) Nutrition and Food Research Institute, Zeist, The Netherlands
    • TNO Prevention and Health, Gaubius Institute, Leiden, The Netherlands

Received 15 November 1994; accepted 30 March 1995.

Abstract 

Impaired fibrinolytic activity has been reported in the elderly and is thought to play a role in the etiology of cardiovascular disease, one of the leading causes of death in most Western countries. Since restriction of energy intake has been demonstrated to act beneficially on the aging process in a variety of species, we studied the effect of a 10-week moderately energy-restricted (ER) regimen (80% of habitual) on plasminogen activator inhibitor (PAl) activity, PAl-1 antigen, tissue plasminogen activator (tPA) activity, and tPA antigen in non-obese, middle-aged men. Moreover, the relationship between these fibrinolytic markers and glucose tolerance was investigated. Weight loss in the ER group (n = 16) was considerable (−7.4 ± 1.7 kg, P < .001). Subjects in the control group (n = 8) also lost some weight (−2.1 ± 1.5 kg, P < .01). Fasting glucose levels decreased in the ER group (−0.31 ± 0.48 mmol/L, P < .05), which was correlated with the extent of weight loss (P < .01). Baseline insulin levels at 2 hours after an oral glucose load correlated with baseline PAl activity (P < .001) and PAl-1 antigen levels (P < .001). PAl activity decreased in the ER group (−2.94 ± 2.90 IU/mL, P < .001), particularly in subjects with a high baseline PAl activity (>9 IU/mL). Furthermore, energy restriction led to decreased PAl-1 antigen concentration (P < .05), a nonsignificant increase in tPA activity, and a decrease in tPA antigen concentration (P < .001). All these changes were more clear in subjects with a high baseline PAl activity: These results suggest that 10 weeks of moderate energy restriction has a profibrinolytic effect in non-obese, middle-aged men, at least in subjects with higher baseline PAl activity (>9 IU/mL). Moreover, in line with the suggestion that high PAl activity goes together with insulin resistance, a relationship between insulin concentration after a glucose load and PAl activity was found.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: 0026-0495(95)90073-X

Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1548-1552, December 1995